JP2021527046A5 - - Google Patents

Info

Publication number
JP2021527046A5
JP2021527046A5 JP2020567808A JP2020567808A JP2021527046A5 JP 2021527046 A5 JP2021527046 A5 JP 2021527046A5 JP 2020567808 A JP2020567808 A JP 2020567808A JP 2020567808 A JP2020567808 A JP 2020567808A JP 2021527046 A5 JP2021527046 A5 JP 2021527046A5
Authority
JP
Japan
Prior art keywords
alkylene
difluoromethoxy
isopropylphenyl
methylpyridine
azetidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020567808A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527046A (ja
JP7386183B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/064690 external-priority patent/WO2019234115A1/en
Publication of JP2021527046A publication Critical patent/JP2021527046A/ja
Publication of JP2021527046A5 publication Critical patent/JP2021527046A5/ja
Application granted granted Critical
Publication of JP7386183B2 publication Critical patent/JP7386183B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567808A 2018-06-07 2019-06-05 Ｌｐａ１受容体アンタゴニストとしてのアルコキシ置換ピリジニル誘導体及び繊維症の治療におけるその使用 Active JP7386183B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2018065016 2018-06-07
EPPCT/EP2018/065016 2018-06-07
PCT/EP2019/064690 WO2019234115A1 (en) 2018-06-07 2019-06-05 Alkoxy-substituted pyridinyl derivatives as lpa1 receptor antagonists and their use in the treatment of fibrosis

Publications (3)

Publication Number Publication Date
JP2021527046A JP2021527046A (ja) 2021-10-11
JP2021527046A5 true JP2021527046A5 (https=) 2022-06-06
JP7386183B2 JP7386183B2 (ja) 2023-11-24

Family

ID=66912779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020567808A Active JP7386183B2 (ja) 2018-06-07 2019-06-05 Ｌｐａ１受容体アンタゴニストとしてのアルコキシ置換ピリジニル誘導体及び繊維症の治療におけるその使用

Country Status (22)

Country Link
US (1) US12344597B2 (https=)
EP (1) EP3802517B1 (https=)
JP (1) JP7386183B2 (https=)
KR (1) KR102826034B1 (https=)
CN (1) CN112236424B (https=)
AU (1) AU2019282274A1 (https=)
BR (1) BR112020024879A2 (https=)
CA (1) CA3102683A1 (https=)
DK (1) DK3802517T3 (https=)
EA (1) EA202092955A1 (https=)
ES (1) ES2940695T3 (https=)
FI (1) FI3802517T3 (https=)
HR (1) HRP20230243T1 (https=)
HU (1) HUE061559T2 (https=)
LT (1) LT3802517T (https=)
MX (1) MX2020013291A (https=)
PL (1) PL3802517T3 (https=)
PT (1) PT3802517T (https=)
RS (1) RS63990B1 (https=)
SI (1) SI3802517T1 (https=)
TW (1) TW202016090A (https=)
WO (1) WO2019234115A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR119162A1 (es) * 2019-06-18 2021-12-01 Idorsia Pharmaceuticals Ltd Derivados de piridin-3-ilo
JP7665619B2 (ja) 2019-12-04 2025-04-21 イドルシア・ファーマシューティカルズ・リミテッド 線維性疾患の治療に使用するためのアゼチジンｌｐａ１受容体アンタゴニストのピルフェニドン及び／又はニンテダニブとの合剤
FI20225388A1 (en) 2022-05-05 2023-11-06 Equinorm Ltd New heterocyclic compounds, preparation methods and their uses
WO2025169931A1 (ja) * 2024-02-05 2025-08-14 Ｕｂｅ株式会社 カルボキサミド化合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130088C (https=) 1960-03-14
GB9420763D0 (en) 1994-10-14 1994-11-30 Glaxo Inc Acetamide derivatives
GB9919776D0 (en) 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
AU7961300A (en) 1999-10-29 2001-05-14 Yamanouchi Pharmaceutical Co., Ltd. Kainic acid neurocytotoxicity inhibitors
AU2001262185A1 (en) 2000-04-10 2001-10-23 Novartis Ag Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
WO2002062389A1 (en) 2001-02-08 2002-08-15 Ono Pharmaceutical Co., Ltd. Remedies for urinary diseases comprising lpa receptor controlling agents
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US7435824B2 (en) 2002-04-19 2008-10-14 Bristol-Myers Squibb Company Prodrugs of potassium channel inhibitors
TW200505902A (en) 2003-03-20 2005-02-16 Schering Corp Cannabinoid receptor ligands
WO2004110350A2 (en) 2003-05-14 2004-12-23 Torreypines Therapeutics, Inc. Compouds and uses thereof in modulating amyloid beta
WO2005023761A2 (en) 2003-09-11 2005-03-17 Kemia, Inc. Cytokine inhibitors
JPWO2005037269A1 (ja) 2003-10-21 2006-12-28 住友製薬株式会社 新規ピペリジン誘導体
EP1687296A1 (en) 2003-11-18 2006-08-09 Warner-Lambert Company LLC Antibacterial aminoquinazolidinedione derivatives
WO2006091862A2 (en) 2005-02-24 2006-08-31 Kemia, Inc. Cytokine inhibitors and their use in therapy
CN101198590B (zh) 2005-08-24 2012-05-09 卫材R&D管理有限公司 吡啶衍生物及嘧啶衍生物（3）
WO2007058990A2 (en) 2005-11-14 2007-05-24 Kemia, Inc. Therapy using cytokine inhibitors
CA2691214A1 (en) 2006-06-09 2007-12-21 Kemia, Inc. Therapy using cytokine inhibitors
JP5164510B2 (ja) 2006-10-06 2013-03-21 日本曹達株式会社 含窒素複素環化合物および有害生物防除剤
WO2008115281A2 (en) 2006-10-16 2008-09-25 Myriad Genetics, Inc. Compounds for treating viral infections
EP2212322B1 (en) 2007-10-18 2012-04-04 Merck Sharp & Dohme Corp. Quinolizidinone m1 receptor positive allosteric modulators
AU2009239500B2 (en) 2008-04-21 2014-01-30 Lexicon Pharmaceuticals, Inc. LIMK2 inhibitors, compositions comprising them, and methods of their use
PT2303270T (pt) 2008-05-05 2017-08-25 Sanofi Sa Derivados fundidos do ácido ciclopentanocarboxílico substituídos por acilamino e sua utilização como produtos farmacêuticos
UY32072A (es) 2008-08-26 2010-03-26 Boehringer Ingelheim Int Tienopirimidinas para composiciones farmacéuticas
KR101678255B1 (ko) * 2009-09-25 2016-11-21 아스텔라스세이야쿠 가부시키가이샤 치환 아미드 화합물
ES2682303T3 (es) 2010-08-05 2018-09-19 Zoetis Services Llc Derivados de isoxazolina como agentes antiparasitarios
TW201305178A (zh) 2010-10-29 2013-02-01 Glenmark Pharmaceuticals Sa 作為ｍＰＧＥＳ－１抑制物的三環化合物
DK2648726T3 (da) 2010-12-07 2018-07-16 Amira Pharmaceuticals Inc Polycyklisk lpa1-antagonist og anvendelser deraf
JP6097998B2 (ja) 2010-12-16 2017-03-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成のビアリールアミドインヒビター
PH12013501831B1 (en) 2011-03-10 2019-06-14 Zoetis Services Llc Spirocyclic isoxazoline derivatives as antiparasitic agents
CA2859965A1 (en) 2011-12-21 2013-06-27 Ardelyx, Inc. Non-systemic tgr5 agonists
WO2014079805A1 (en) 2012-11-23 2014-05-30 Boehringer Ingelheim International Gmbh Pyrazole compounds for treating hairloss
EP2970200A1 (en) * 2013-03-13 2016-01-20 Abbvie Inc. Pyridine cdk9 kinase inhibitors
AR108185A1 (es) 2016-04-06 2018-07-25 Abbvie Inc Amidas terciarias y método para su uso
AR119162A1 (es) 2019-06-18 2021-12-01 Idorsia Pharmaceuticals Ltd Derivados de piridin-3-ilo
JP7665619B2 (ja) 2019-12-04 2025-04-21 イドルシア・ファーマシューティカルズ・リミテッド 線維性疾患の治療に使用するためのアゼチジンｌｐａ１受容体アンタゴニストのピルフェニドン及び／又はニンテダニブとの合剤

Similar Documents

Publication Publication Date Title
JP2021527046A5 (https=)
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
CN116531380B (zh) 用于治疗癌症的2-杂芳基-3-氧代-2,3-二氢哒嗪-4-甲酰胺
FI3802517T3 (fi) Alkoksisubstituoituja pyridinyylijohdannaisia LPA1-reseptoriantagonisteina ja niiden käyttö fibroosin hoidossa
JP2016503009A5 (https=)
JP2008517945A5 (https=)
JP2022530049A5 (https=)
JP2014525444A5 (https=)
JP2016526576A5 (https=)
JP2009536197A5 (https=)
EP3022202A1 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
HRP20161011T1 (hr) Aril dihidropiridinoni i piperidinoni kao inhibitori mgat2
JP2015501799A5 (https=)
HRP20160539T1 (hr) Antagonisti trpv4
JP2012525349A5 (https=)
RU2016108753A (ru) Ингибиторы ферментов
JP2009510043A5 (https=)
RU2006127572A (ru) Полигетероциклические соединения и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2014521696A5 (https=)
JP2006506380A5 (https=)
HRP20160421T1 (hr) Derivat azola
JP2013527847A5 (https=)
JPWO2020262603A5 (https=)
HRP20240297T1 (hr) Derivati alfa-d-galaktopiranozida
JP2022537177A5 (https=)